Breaking News: Sinaptica’s Noninvasive Neuromodulation Device Slows Alzheimer’s Disease in Year-Long Trial

Hear the latest groundbreaking news in Alzheimer’s research. Sinaptica, a member of StartUp Health’s Alzheimer’s Moonshot Community, has announced significant results from its Phase 2 clinical trial testing the company’s noninvasive, personalized, prec...